Zoryve Cream Now Available for Plaque Psoriasis
Zoryve cream 0.3% is now available for the treatment of plaque psoriasis, including intertriginous areas, in patients aged ≥12 years.
Source: empr.com
Stay updated with breaking news from Zoryve Direct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zoryve cream 0.3% is now available for the treatment of plaque psoriasis, including intertriginous areas, in patients aged ≥12 years.
The FDA has approved Zoryve cream for the treatment of plaque psoriasis, Arcutis announced in a press release. A nonsteroid, phosphodiesterase-4 inhibitor, Zoryve (roflumilast cream 0.3%) is a once-daily topical treatment for psoriasis and the first PDE4 inhibitor approved for this indication.